|Pregnancy and family planning for people living with HIV (PLWH) can be a challenge, and there are new updates to guidelines for the use of antiretroviral therapy (ART) with patients of childbearing potential that clinicians treating these patients need to know. Risks of mother-to-child transmission of HIV during pregnancy, through delivery and breastfeeding/postnatal care, require that clinicians working with PLWH understand treatment options to be able to counsel patients on the management of HIV throughout family planning, conception, pregnancy and postnatal care.
This CMEO BriefCase entitled, Antiretroviral Therapy (ART) for People Living With HIV (PLWH) Who Are Pregnant or of Childbearing Potential, will discuss a specific case of using ART to treat HIV in a patient who plans to and becomes pregnant while being treated for HIV. Expert faculty will discuss new guidelines for the treatment of HIV before, during, and following pregnancy and the prevention of the transmission of HIV throughout these stages.
Integrate guideline recommended HIV treatment into perinatal care.
This program has been supported by an independent educational grant from Gilead Sciences, Inc.
Primary care physicians, physician associates (PAs), nurse practitioners (NPs), nurses, and pharmacists specializing in HIV.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Chakraborty reports the following financial relationships:
Research Support: Extramural Grant from National Institutes of Health (NIH)
Dr. Levison reports no financial relationships to disclose.
Disclosures were obtained from the CME Outfitters, LLC staff; no disclosures to report:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Call us at 877.CME.PROS (877.263.7767).